U.S. FDA Fast-tracks Nektar Therapeutics’ Rezpegaldesleukin for Severe-to-Very-Severe AA July 29, 2025
Data Dive: Key Insights From the 2025 ASDS Consumer Survey on Cosmetic Dermatologic Procedures July 28, 2025